This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a McGill University directory, so their publications, courses and email address may be missing. Find their university profile.
Research
Latest funding
- $1,510,875
Altering the gut microbiome in Triple- negative breast cancer: a pilot study
CIHR · 2024 · Principal investigator
- $100,000
Altering the gut microbiome in Triple- negative breast cancer: a pilot study
CIHR · 2023 · Principal investigator
Altering the gut microbiome in Triple- negative breast cancer: a pilot study
Principal investigators: Basik, Mark; Maleki, Saman; Ng, Terry L
Keywords: Ctdna; Fecal Microbial Transplant; Neoadjuvant; Pembrolizumab; Tnbc
Altering the gut microbiome in Triple- negative breast cancer: a pilot study
Principal investigators: Basik, Mark; Maleki, Saman; Ng, Terry L
Keywords: Circulating Tumor Dna; Fecal Microbiota Transplantation; Neoadjuvant Chemotherapy; Pembrolizumab; Triple Negative Breast Cancer
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.